Search filters

List of works by Corinna La Rosa

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

scientific article published on 03 October 2018

A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models

scientific article published on 13 August 2008

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

scientific article

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells.

scientific article

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells.

scientific article published on 2 April 2015

Characterization of host immunity to cytomegalovirus pp150 (UL32).

scientific article

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

scientific article

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant

scientific article published on 7 March 2012

Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice"

scientific article published on 13 November 2019

Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.

scientific article

Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients

scientific article

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients

scientific article

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex

scientific article published on 20 November 2014

Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge ⬇️

scientific article published on October 15, 2003

In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara

scientific article published on April 2006

Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses

scientific article

La Rosa C et al (J Infect Dis 2012; 205:1294–304).

scientific article published in September 2013

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease

scientific article

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

scientific article

Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

scientific article published on 27 February 2009

Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines

scientific article

Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

scholarly article by Flavia Chiuppesi et al published 1 October 2018 in Journal of Virology

Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients

scientific article

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

scientific article published on 11 February 2020

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.

scientific article published on 12 July 2002

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

scientific article

Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.

scientific article

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax

scientific article published on 16 December 2018

Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus

scientific article published on April 2004

Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.

scientific article

Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles

scientific article published in April 2003

The immune response to human CMV

scientific article published on March 2012

Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

scientific article published on 6 October 2006

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

scientific article

Paulina is supported by:

About Paulina

Help